NCT05093192View on ClinicalTrials.gov

Mobilising Tumour and Immune Cells Via Exercise in Chronic Lymphocytic Leukaemia

NACompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

October 1, 2021

Primary Completion Date

December 6, 2022

Study Completion Date

December 6, 2022

Conditions
Chronic Lymphocytic LeukemiaMinimal Residual Disease
Interventions
OTHER

Exercise trial

Participants will perform a supervised acute bout of aerobic exercise over 20-30 minutes, corresponding to a target power output at an intensity +10 to 15% above ventilatory threshold.

Trial Locations (2)

BA1 3NG

Royal United Hospital Bath NHS Foundation Trust, Bath

BA2 7AY

University of Bath, Bath

All Listed Sponsors
collaborator

Royal United Hospitals Bath NHS Foundation Trust

OTHER

collaborator

University of Southampton

OTHER

collaborator

Great Western Hospitals NHS Foundation Trust

OTHER

lead

University of Bath

OTHER

NCT05093192 - Mobilising Tumour and Immune Cells Via Exercise in Chronic Lymphocytic Leukaemia | Biotech Hunter | Biotech Hunter